X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs VENUS REMEDIES - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD VENUS REMEDIES ORCHID PHARMA LTD/
VENUS REMEDIES
 
P/E (TTM) x -0.8 -850.0 - View Chart
P/BV x 0.6 0.2 228.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   VENUS REMEDIES
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
VENUS REMEDIES
Mar-16
ORCHID PHARMA LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs194218 89.0%   
Low Rs3582 42.6%   
Sales per share (Unadj.) Rs276.5365.6 75.6%  
Earnings per share (Unadj.) Rs-79.21.5 -5,330.3%  
Cash flow per share (Unadj.) Rs-43.537.9 -114.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.9382.5 14.1%  
Shares outstanding (eoy) m70.4511.44 615.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.40.4 100.9%   
Avg P/E ratio x-1.4101.0 -1.4%  
P/CF ratio (eoy) x-2.64.0 -66.6%  
Price / Book Value ratio x2.10.4 541.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0671,717 469.9%   
No. of employees `0002.81.0 274.5%   
Total wages/salary Rs m2,527324 779.0%   
Avg. sales/employee Rs Th6,956.14,100.7 169.6%   
Avg. wages/employee Rs Th902.5318.0 283.8%   
Avg. net profit/employee Rs Th-1,993.016.7 -11,957.8%   
INCOME DATA
Net Sales Rs m19,4774,183 465.7%  
Other income Rs m40720 2,025.9%   
Total revenues Rs m19,8844,203 473.1%   
Gross profit Rs m1,103812 135.9%  
Depreciation Rs m2,519417 604.4%   
Interest Rs m5,227380 1,376.2%   
Profit before tax Rs m-6,23635 -17,767.0%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-12518 -691.7%   
Profit after tax Rs m-5,58017 -32,825.3%  
Gross profit margin %5.719.4 29.2%  
Effective tax rate %2.051.6 3.9%   
Net profit margin %-28.70.4 -7,049.3%  
BALANCE SHEET DATA
Current assets Rs m11,0142,771 397.5%   
Current liabilities Rs m32,0601,931 1,660.0%   
Net working cap to sales %-108.120.1 -538.5%  
Current ratio x0.31.4 23.9%  
Inventory Days Days95125 75.9%  
Debtors Days Days3454 62.4%  
Net fixed assets Rs m29,4405,328 552.5%   
Share capital Rs m705114 615.8%   
"Free" reserves Rs m2,0434,177 48.9%   
Net worth Rs m3,8004,376 86.8%   
Long term debt Rs m9,0181,911 472.0%   
Total assets Rs m46,5108,428 551.8%  
Interest coverage x-0.21.1 -17.7%   
Debt to equity ratio x2.40.4 543.6%  
Sales to assets ratio x0.40.5 84.4%   
Return on assets %-0.84.7 -16.1%  
Return on equity %-146.90.4 -37,804.0%  
Return on capital %-3.76.6 -56.6%  
Exports to sales %37.90-   
Imports to sales %22.620.5 110.2%   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406858 513.3%   
Fx inflow Rs m7,5130-   
Fx outflow Rs m5,649858 658.1%   
Net fx Rs m1,865-858 -217.2%   
CASH FLOW
From Operations Rs m1,682469 358.7%  
From Investments Rs m-9,86029 -33,768.5%  
From Financial Activity Rs m6,644-464 -1,433.4%  
Net Cashflow Rs m-1,53535 -4,449.3%  

Share Holding

Indian Promoters % 32.3 32.9 98.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 0.2 2,555.6%  
FIIs % 3.3 0.6 569.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 66.4 83.3%  
Shareholders   84,811 20,121 421.5%  
Pledged promoter(s) holding % 54.9 36.4 151.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 17, 2017 01:42 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - PFIZER COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS